|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Perfor- mance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results 显示文摘 | Reuschenbach M Clad A von Knebel Doeberitz C | 2010 | Gynecnl Oncol2010，1119，1： | 1 |
| 2 | High-risk human papillomavirus in non-melanoma skin lesions from renal allograft recipients and immunocompetent patients 显示文摘 | Reuschenbach M Tran T Fanlstich F | 2011 | Br J Cancer2011，104，： | 1 |
| 3 | Char- acterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-as-sociated cancers显示文摘 | Reuschenbach M Waterboer T Wallin KL | 2008 | Int J Cancer2008，123，11： | 1 |
| 4 | Biomarkers for cervical cancer screening: the role of p 16 (INKga) to highlight transforming HPV infections 显示文摘 | von Knebel Doeberitz M Reuschenbach M Schmidt D | 2012 | Expert Rev Proteomics2012，9，2： | 1 |
| 5 | P16INK4a immunocytoehemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysis 显示文摘 | Roelens J Reuschenbach M von Knebel Doeberitz M | 2012 | Cancer Cytopathol2012，120，5： | 1 |
| 6 | The clinical impact of using pl6jNK4 immunoehemistry in cervical histopathology and cy- tology: an update of recent developments 显示文摘 | Bergeren C Ronco G Reuschenbach M | 2015 | Int J Cancer2015，136，12： | 1 |
| 7 | The clinical impact of using p16 immunochemistry in cervical histopathology and cytology: an update of recentdevelopments显示文摘 | Bergeron C Ronco G Reuschenbach M | 2014 | Int J Cancer2014，12，3： | 1 |
| 8 | Perform- ance of the Aptima high-risk human papillomavirus mR- NA assay in a referral population in comparison with Hy- brid Capture 2 and cytology显示文摘 | Clad A Reuschenbach M Weinschenk J | 2011 | J Clin Microbiol2011，49，3： | 1 |
| 9 | pl6INK4a im- munocytoehemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities 显示文摘 | Roelens J Reuschenbach M Knebel-Doeberitz M | 2012 | Cancer Cyto- pathal2012，120，5： | 1 |
| 10 | T cell responses against microsatellite instability-induced frameshift peptides and influence of regulatory T cells in colorectal cancer显示文摘 | Bauer K Nelius N Reuschenbach M | 2013 | Cancer Immunol Immunother2013，62，1： | 1 |
| 11 | T cell responses against mierosatellite instability-induced frameshift peptides and influence of regulatory T ceils in colorectal cancer 显示文摘 | Bauer K Nelius N Reuschenbach M | 2013 | Cancer Immunology Immunotherapy2013，62，1： | 1 |
| 12 | Laboratory Shake Flask Batch Tests can Predict Field Biodegradation of Aniline in the Rhine 显示文摘 | Lars Tor'ang Peter Reuschenbach Britta M/iller | 2002 | Chemosphere2002，49，10： | 1 |
| 13 | Characterization of humoral immune responses againstpl6, p53, HPV 16 E6 and HPV 16 E7 in patients with HPV-associated cancers显示文摘 | Reuschenbach M Waterboer T Wallin KL | 2008 | Int J Cancer2008，123，11： | 1 |
| 14 | Oncogenic human papillomaviruses activate the tumor-associated lens epithelial-derived growth factor(LEDGF)gene显示文摘 | Leitz J Reuschenbach M Lohrey C | 2014 | PLo S Pathog2014，10，10： | 1 |
| 15 | Characterization of humoral immune responses against P16, P53, HPV16 E6 and HPV16 E7 in patients with PHV-associated cancers 显示文摘 | Reuschenbach M Waterboer T Wallin KL | 2008 | Int J Cancer2008，123，11： | 1 |
| 16 | Perfor-mance of pl6INK4a-cytology,HPV mRNA, and HPVDNA testing to identify high grade cervical dysplasia inwomen with abnormal screening results 显示文摘 | REUSCHENBACH M CLAD A VON KDC | 2010 | Gynecol On-col2010，119，1： | 1 |
| 17 | Perform- ance of P16 INK4a-cytology, HPV DNA mRNA, and HPV DNA tes- ting to identify high grade cervical dysplasia in women with abnormal screening results 显示文摘 | Reuschenbach M Clad A yon Knebel Doeberitz C | 2010 | Gynecologic Oncology2010，119，1： | 1 |
| 18 | A systematic review of humoral immune responses against tumor antigens显示文摘 | Reuschenbach M von Knebel Doeberitz M Wentzensen N | 2009 | Cancer Immunol Immun2009，58，10： | 1 |
| 19 | Perform- ance of P16 INK4a- cytology, HPV DNA mRNA, and HPV DNA tes- ting to identify high grade cervical dysplasia in women with abnormal screening results 显示文摘 | Reuschenbach M Clad A yon Knebel Doeberitz C | 2010 | Gynecologic oncology2010，119，1： | 1 |
| 20 | Performance of p16ink4acytology,HPV mRNA,and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results显示文摘 | Reuschenbach M Clad A von Knebel Doeberitz C | 2010 | Gynecol Oncol2010，119，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员